ABOT Abbott Laboratories (Pakistan) Limited
Latest results: FY2025 · Dec 2025 Q2 FY2026 · Apr – Jun 2026
Last close · 16 Oct 2026
Rs 944.39 +1.11%
Financials
Abbott Laboratories (Pakistan) Limited (ABOT) financials
20 years of annual results (FY2006 – FY2025), 80 quarters.
Abbott Laboratories (Pakistan) Limited (ABOT) reported revenue of Rs 75.4 bn for FY2025 (Jan – Dec 2025), up 10.6% from FY2024.
Profit attributable to shareholders was Rs 8.0 bn (EPS Rs 81.37), up 52.2%, a net margin of 10.6%.
It declared a dividend of Rs 40.00 per share for FY2025.
The balance sheet showed net cash of Rs 12.8 bn.
Return on equity was 28.8%.
Over the last five years revenue grew at a compound 16.4% a year.
At Rs 944.39 (close on 16 Oct 2026) the shares trade at 10.8× earnings (TTM to Jun 2026) and 2.88× book value, with a dividend yield of 4.2%.
Fundamentals
ABOT at a glance
Revenue · FY2025
Rs 75.4 bn
▲ 10.6% year on year
Profit attributable to shareholders · FY2025
Rs 8.0 bn
▲ 52.2% year on year
EPS – basic (Rs) · FY2025
Rs 81.37
▲ 52.2% year on year
Dividend per share (Rs) · FY2025
Rs 40.00
▲ 300.0% year on year
Net margin · FY2025
10.6%
+2.9 pts year on year
Debt to equity · FY2025
1.5%
+1.3 pts year on year
Financial statements
Income statement
Revenue, costs, profit and earnings per share.
- Revenue · FY2025
- Rs 75.4 bn
- Profit attributable · FY2025
- Rs 8.0 bn
Balance sheet
Assets, liabilities, debt and shareholders' equity.
- Total assets · FY2025
- Rs 46.8 bn
- Equity · FY2025
- Rs 31.6 bn
Financial highlights
ABOT financial results
| Rs bn | FY2025 Jan – Dec 2025 | FY2024 Jan – Dec 2024 | FY2023 Jan – Dec 2023 | FY2022 Jan – Dec 2022 | FY2021 Jan – Dec 2021 | FY2020 Jan – Dec 2020 | FY2019 Jan – Dec 2019 | FY2018 Jan – Dec 2018 | FY2017 Jan – Dec 2017 | FY2016 Jan – Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 75.4 | 68.2 | 55.5 | 49.3 | 42.6 | 35.3 | 30.2 | 29.7 | 26.1 | 23.4 |
| Gross profit | 26.8 | 20.0 | 11.8 | 14.5 | 16.1 | 12.2 | 8.5 | 9.8 | 10.1 | 9.4 |
| Operating profit | 13.2 | 8.9 | 3.2 | 6.1 | 7.8 | 6.1 | 2.5 | 4.4 | 5.5 | 5.2 |
| Profit after tax | 8.0 | 5.2 | 0.3 | 3.0 | 6.0 | 4.5 | 1.3 | 2.7 | 4.2 | 4.0 |
| Profit attributable to shareholders | 8.0 | 5.2 | 0.3 | 3.0 | 6.0 | 4.5 | 1.3 | 2.7 | 4.2 | 4.0 |
| EPS – basic (Rs) Rs | 81.37 | 53.46 | 2.67 | 30.69 | 60.95 | 46.33 | 13.28 | 27.52 | 42.95 | 41.08 |
| Dividend per share (Rs) Rs | 40.00 | 10.00 | 0.00 | 15.00 | 40.00 | 40.00 | 7.50 | 20.00 | 40.00 | 40.00 |
| Total assets | 46.8 | 37.7 | 36.7 | 33.9 | 28.6 | 24.9 | 20.8 | 20.3 | 19.2 | 17.6 |
| Total equity | 31.6 | 23.7 | 18.2 | 17.1 | 17.4 | 15.6 | 13.4 | 13.2 | 14.4 | 14.6 |
| Total debt | 0.5 | 0.1 | 0.2 | 0.2 | 0.2 | 0.8 | 0.4 | 0.2 | 0.0 | — |
| Net cash from operating activities | 11.2 | 5.1 | 0.7 | 4.7 | 8.4 | 8.5 | 0.1 | 3.3 | 6.1 | 3.5 |
| Capital expenditure | (3.3) | (3.0) | (3.1) | (3.6) | (2.1) | (1.4) | (1.9) | (2.3) | (1.6) | (1.0) |
| Free cash flow (operating cash flow − capex) | 7.9 | 2.1 | (2.4) | 1.1 | 6.3 | 7.1 | (1.8) | 1.0 | 4.5 | 2.5 |
| Rs bn | TTM to Jun 2026 | Q2 FY2026 Apr – Jun 2026 | Q1 FY2026 Jan – Mar 2026 | Q4 FY2025 Oct – Dec 2025 | Q3 FY2025 Jul – Sep 2025 | Q2 FY2025 Apr – Jun 2025 | Q1 FY2025 Jan – Mar 2025 | Q4 FY2024 Oct – Dec 2024 | Q3 FY2024 Jul – Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 77.0 | 20.3 | 17.7 | 19.2 | 19.8 | 19.1 | 17.3 | 18.6 | 17.4 |
| Gross profit | 28.3 | 7.8 | 6.7 | 7.1 | 6.7 | 6.8 | 5.8 | 5.6 | 5.8 |
| Operating profit | 13.8 | 3.7 | 3.1 | 3.9 | 3.1 | 3.3 | 2.6 | 3.1 | 2.9 |
| Profit after tax | 8.6 | 2.2 | 1.9 | 2.6 | 1.8 | 1.9 | 1.6 | 1.3 | 1.8 |
| Profit attributable to shareholders | 8.6 | 2.2 | 1.9 | 2.6 | 1.8 | 1.9 | 1.6 | 1.3 | 1.8 |
| EPS – basic (Rs) Rs | 87.47 | 22.47 | 19.82 | 26.56 | 18.62 | 19.85 | 16.34 | 13.12 | 18.48 |
| Dividend per share (Rs) Rs | 40.00 | 0.00 | 0.00 | 40.00 | 0.00 | 0.00 | 0.00 | 10.00 | 0.00 |
| Total assets | 48.8 | 48.8 | 50.2 | 46.8 | 44.5 | 42.2 | 39.3 | 37.7 | 37.3 |
| Total equity | 32.1 | 32.1 | 33.7 | 31.6 | 28.4 | 26.4 | 24.4 | 23.7 | 22.4 |
| Total debt | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.1 | 0.1 | 0.1 |
| Net cash from operating activities | 9.1 | 1.5 | (0.4) | 5.8 | 2.2 | 2.3 | 0.9 | 3.3 | 1.2 |
| Capital expenditure | (2.8) | (0.6) | (0.5) | (1.4) | (0.3) | (0.9) | (0.6) | (1.1) | (0.9) |
| Free cash flow (operating cash flow − capex) | 6.2 | 0.8 | (0.9) | 4.4 | 1.9 | 1.4 | 0.3 | 2.2 | 0.3 |
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 16 Oct 2026.